Engineers at the University of California San Diego have developed neutrophil "nanosponges" that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering the nanosponges early on also prevented the disease from developing. The work was published online on September 3, 2018 in Nature Nanotechnology. The article is titled “Neutrophil Membrane-Coated Nanoparticles Inhibit Synovial Inflammation and Alleviate Joint Damage in Inflammatory Arthritis.” "Nanosponges are a new paradigm of treatment to block pathological molecules from triggering disease in the body," said senior author Dr. Liangfang Zhang, a nanoengineering professor at the UC San Diego Jacobs School of Engineering. "Rather than creating treatments to block a few specific types of pathological molecules, we are developing a platform that can block a broad spectrum of them, and this way we can treat and prevent disease more effectively and efficiently." This work is one of the latest examples of therapeutic nanosponges developed by Dr. Zhang's lab. Dr. Zhang, who is affiliated with the Institute of Engineering in Medicine and Moores Cancer Center at UC San Diego, and his team previously developed red blood cell nanosponges (http://jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=1350) to combat and prevent MRSA (methicillin-resistant Staphylococcus aureus) infections and macrophage nanosponges (http://jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=2400) to treat and manage sepsis. The new nanosponges are nanoparticles of biodegradable polymer coated with the cell membranes of neutrophils, a type of white blood cell.
Login Or Register To Read Full Story